SK12772000A3 - 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie - Google Patents

3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie Download PDF

Info

Publication number
SK12772000A3
SK12772000A3 SK1277-2000A SK12772000A SK12772000A3 SK 12772000 A3 SK12772000 A3 SK 12772000A3 SK 12772000 A SK12772000 A SK 12772000A SK 12772000 A3 SK12772000 A3 SK 12772000A3
Authority
SK
Slovakia
Prior art keywords
triazolo
phthalazine
methyl
methylisoxazol
methyloxy
Prior art date
Application number
SK1277-2000A
Other languages
English (en)
Slovak (sk)
Inventor
William Robert Carling
Tamara Ladduwahetty
Angus Murray Macleod
Kevin John Merchant
Kevin William Moore
Francine Sternfeld
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803992.8A external-priority patent/GB9803992D0/en
Priority claimed from PCT/GB1998/001307 external-priority patent/WO1998050385A1/en
Priority claimed from GBGB9824896.6A external-priority patent/GB9824896D0/en
Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited
Publication of SK12772000A3 publication Critical patent/SK12772000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK1277-2000A 1998-02-25 1999-02-17 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie SK12772000A3 (sk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9803992.8A GB9803992D0 (en) 1998-02-25 1998-02-25 Therapeutic agents
PCT/GB1998/001307 WO1998050385A1 (en) 1997-05-08 1998-05-06 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GBGB9824896.6A GB9824896D0 (en) 1998-11-12 1998-11-12 Therapeutic compound
PCT/GB1999/000485 WO1999043677A1 (en) 1998-02-25 1999-02-17 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE

Publications (1)

Publication Number Publication Date
SK12772000A3 true SK12772000A3 (sk) 2001-03-12

Family

ID=27269184

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1277-2000A SK12772000A3 (sk) 1998-02-25 1999-02-17 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie

Country Status (14)

Country Link
EP (1) EP1070066A1 (ru)
JP (1) JP2002504554A (ru)
CN (1) CN1291194A (ru)
AU (1) AU746719B2 (ru)
BG (1) BG104705A (ru)
CA (1) CA2317416A1 (ru)
EA (1) EA002824B1 (ru)
HR (1) HRP20000555A2 (ru)
HU (1) HUP0100647A3 (ru)
NZ (1) NZ505695A (ru)
PL (1) PL341975A1 (ru)
SK (1) SK12772000A3 (ru)
TR (1) TR200002469T2 (ru)
WO (1) WO1999043677A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH21834A (en) * 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
CA2260900A1 (en) * 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited Substituted triazolo pyridazine derivatives as inverse agonists of the gabaa.alpha.5 receptor subtype
AU732455C (en) * 1997-05-08 2002-09-05 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands

Also Published As

Publication number Publication date
WO1999043677A1 (en) 1999-09-02
HUP0100647A2 (hu) 2001-09-28
EP1070066A1 (en) 2001-01-24
CA2317416A1 (en) 1999-09-02
PL341975A1 (en) 2001-05-07
HRP20000555A2 (en) 2001-08-31
CN1291194A (zh) 2001-04-11
NZ505695A (en) 2002-03-01
BG104705A (bg) 2001-04-30
TR200002469T2 (tr) 2000-12-21
EA200000878A1 (ru) 2001-02-26
HUP0100647A3 (en) 2003-03-28
AU2536899A (en) 1999-09-15
JP2002504554A (ja) 2002-02-12
EA002824B1 (ru) 2002-10-31
AU746719B2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
US6313125B1 (en) Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors
CZ290883B6 (cs) Triazolopyridazinové deriváty, způsob jejich výroby a farmaceutický prostředek je obsahující
JP2000515851A (ja) GABA▲下Aα5▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体
JP2002501070A (ja) Gaba受容体のリガンドとしてのトリアゾロ−ピリダジン誘導体
WO2006108488A1 (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
CZ20004872A3 (cs) Substituovaný triazolopyridazinový derivát
JP2002501071A (ja) Gaba受容体のリガンドとしてのトリアゾロ−ピリダジン誘導体
US6949549B2 (en) Imidazolophthalazine derivatives as ligands for GABAA receptors
JP2002501069A (ja) Gaba受容体のためのリガンドとしてのトリアゾロ−ピリダジン誘導体
US6297235B1 (en) Triazolopyridazine derivatives for treating anxiety and enhancing cognition
SK12772000A3 (sk) 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie
US6448249B1 (en) Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
JP2002536449A (ja) Gabaレセプターに対するリガンドとしてのトリアゾロ−ピリダジン誘導体
US6946461B2 (en) Imidazolophthalazine derivatives as ligands for GABAA receptors
US6613766B1 (en) Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors
US7022724B2 (en) Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands
CA2631034A1 (en) Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
JP2001519350A (ja) ナフト−イミダゾ[1,2−a]ピリジン誘導体、その製造及び中枢神経系障害の処置におけるその使用
MXPA00008320A (en) SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE
HRP980584A2 (en) SUBSTITUTED 1,2,4-TRIAZOLO/3,4-a/ PHTHALAZINE